Filter by: patients
Home > Community Treatment Reports and Side Effects > Hydromorphone Treatment Report
What is Hydromorphone?

Hydromorphone (trade names Palladone IR, Palladone SR, Dilaudid and numerous others) is a potent centrally-acting analgesic drug of the opioid class; it is a derivative of morphine, specifically a hydrogenated ketone thereof -- therefore a semi-synthetic drug and both an opiate and a true narcotic.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Pain 68 16 Efficacy_major Efficacy_moderate Efficacy_slight
Chronic pain 20 3 Efficacy_major Efficacy_moderate
Fibromyalgia 19 4 Efficacy_major Efficacy_moderate
Breakthrough pain 10 2 Efficacy_moderate
Pain in lower back 8 2 Efficacy_major Efficacy_slight
Other 7 3 Efficacy_major Efficacy_moderate

See all 128 patients currently taking Hydromorphone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 11
Mild
 11
None
 11

Commonly reported side effects, conditions, and hospitalizations associated with Hydromorphone

Drowsiness 4
Constipation 4
Nausea 3
Nausea and vomiting 2
Dizziness 1
Brain fog 1
See all 25 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Hydromorphone. See all 43 dosages ►

  2 4mg as needed 2mg as needed 8mg as needed 4mg as needed 4 mg daily 6 mg daily 8 mg daily 12 mg daily 16 mg daily 24 mg daily
  4 Number of Patients: 4 19 Number of Patients: 19 7 Number of Patients: 7 19 Number of Patients: 19 11 Number of Patients: 11 8 Number of Patients: 8 7 Number of Patients: 7 6 Number of Patients: 6 6 Number of Patients: 6 6 Number of Patients: 6  

Reported Stop Reasons

Why Patients Stopped Taking Hydromorphone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 10   Side effects too severe: 32%
Course of treatment ended 8   Course of treatment ended: 26%
Other 6   Other: 19%
Doctor's advice 6   Doctor's advice: 19%
Did not seem to work 5   Did not seem to work: 16%
Change in health plan coverage 1   Change in health plan coverage: 3%
Not indicated 1   Not indicated: 3%

See all 30 patients who’ve stopped taking Hydromorphone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Hydromorphone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Hydromorphone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Hydromorphone

Always
 22 63%
Usually
 10 29%
Sometimes
 1 3%
Never
 2 6%

Burden

Difficulty being on treatment

Burden of Hydromorphone

Very
 4 11%
Somewhat
 1 3%
A little
 8 23%
Not at all
 22 63%

Cost

Paid out of pocket

Cost of Hydromorphone

$200+
 0 0%
$100-199
 4 22%
$50-99
 1 6%
$25-49
 0 0%
< $25
 13 72%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 10, 2012.